(Q51565817)

7 April 2018

review article

1 reference

title

Sibutramine. A review of its contribution to the management of obesity. (English)

1 reference

7 April 2018

0 references

W McNeely

1

1 reference

7 April 2018

K L Goa

series ordinal

2

1 reference

7 April 2018

publication date

1 December 1998

1 reference

7 April 2018

published in

Drugs

1 reference

7 April 2018

volume

56

1 reference

7 April 2018

page(s)

1093-1124

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.2165/00003495-199856060-00019

exact match

0 references

cites work

A double-blind randomized placebo-controlled trial of sibutramine

1 reference

12 December 2020

Obesity in Europe: prevalence and consequences for use of medical care.

1 reference

12 December 2020

The NAASO position paper on approval and use of drugs to treat obesity

1 reference

12 December 2020

D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function

1 reference

12 December 2020

Sibutramine--a review of clinical efficacy

1 reference

12 December 2020

The economics of treating obesity

1 reference

12 December 2020

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

1 reference

12 December 2020

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

1 reference

12 December 2020

Socioeconomic consequences of obesity: the effect of obesity on the individual

1 reference

12 December 2020

Beneficial health effects of modest weight loss

1 reference

12 December 2020

The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride

1 reference

12 December 2020

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

12 December 2020

Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.

1 reference

12 December 2020

Sibutramine: a review of the pharmacology of a novel anti-obesity agent

1 reference

12 December 2020

Drugs of abuse: biochemical surrogates of specific aspects of natural reward?

1 reference

12 December 2020

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

12 December 2020

Long-term intervention strategies in obesity treatment

1 reference

12 December 2020

Appetite suppressants. A review

1 reference

12 December 2020

Weight cycling. National Task Force on the Prevention and Treatment of Obesity

1 reference

12 December 2020

Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting

1 reference

12 December 2020

Guidelines tackle tidal wave of obesity

1 reference

12 December 2020

Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat

1 reference

12 December 2020

The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation.

1 reference

12 December 2020

Causes, diagnosis and risks of obesity

1 reference

12 December 2020

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.

1 reference

12 December 2020

Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex

1 reference

12 December 2020

Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl

1 reference

12 December 2020

Sibutramine in weight control: a dose-ranging, efficacy study.

1 reference

12 December 2020

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

1 reference

12 December 2020

[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.

1 reference

12 December 2020

Venlafaxine. A review of its pharmacology and therapeutic potential in depression

1 reference

12 December 2020

The indirect costs of obesity to society

1 reference

12 December 2020

Guidelines for the approval and use of drugs to treat obesity. A position paper of The North American Association for the Study of Obesity

1 reference

12 December 2020

A comparison of various antidepressant drugs demonstrates rapid desensitisation of alpha 2-adrenoceptors exclusively by sibutramine hydrochloride.

1 reference

12 December 2020

Waist circumference as a measure for indicating need for weight management.

1 reference

12 December 2020

Worldwide epidemiology of obesity

1 reference

12 December 2020

A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine

1 reference

12 December 2020

Classification of drugs according to their discriminable effects in rats

1 reference

12 December 2020

10.2165/00003495-199856060-00019

Identifiers

DOI

1 reference

7 April 2018

Dimensions Publication ID

0 references

1 reference

7 April 2018